NIVOLUMAB

Clinical trials for NIVOLUMAB explained in plain language.

Never miss a new study

Get alerted when new NIVOLUMAB trials appear

Sign up with your email to follow new studies for NIVOLUMAB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New drug cocktail targets Hard-to-Treat colorectal cancer

Disease control Terminated

This study tests whether a combination of four drugs (BMS-986340, nivolumab, trifluridine/tipiracil, and bevacizumab) can help control advanced colorectal cancer that has stopped responding to standard treatments. The trial includes 7 adults with a specific type of cancer called …

Matched conditions: NIVOLUMAB

Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 26, 2026 11:02 UTC

NIVOLUMAB

Get alerted when new NIVOLUMAB trials appear

New drug cocktail targets Hard-to-Treat colorectal cancer